Explore our stories on COVID-19 and past pandemics.
If you have a compromised immune system, you can be fully vaccinated, but still not protected against COVID-19.
If you thought vaccinating the whole U.S. was hard, the challenges only grow on a worldwide scale.
A new study suggests around a third of COVID-19 patients have long-term symptoms.
California stresses equity for minority groups. Texas is all about personal choice and liberty. Both states face roadblocks.
Plus, the latest on the U.S.’s homegrown COVID-19 variants and Google’s data tracking changes.
Recent studies showing that a single dose of vaccine could boost immunity for former COVID-19 patients.
NIAID Director Anthony Fauci sheds light on vaccines, variants, and a return to normalcy.
Small numbers of patients seem to be incubators for coronavirus mutation. What does this mean for our efforts to fight the virus?
SciFri listeners called with questions ranging from how antibodies work to who should get jabbed. A microbiologist provides the answers.
Vaccines are being tested against new variants of the coronavirus. Here’s what the latest data are telling us.
Why the CDC may update its guidance on masking, plus more science news stories from the week.
President Biden’s national COVID-19 relief effort aims to administer 100 million vaccinations in 100 days.
How decades of vaccine research, financial investment, and a bit of luck gave scientists the tools to quickly create—and test—vaccines for COVID-19.
Why has New York struggled to distribute COVID-19 vaccines, while West Virginia excelled?
Virologist Angela Rasmussen explains the virus variant and the latest controversy of the vaccine distribution.
Pfizer’s promising press release about its vaccine’s efficacy wasn’t accompanied by data. Experts explain the implications.
Two encouraging COVID-19 vaccine trials reported strong clinical results this week. So what comes next?
There’s no way to have a completely safe in-person gathering this holiday season. But if you’re going to see friends and family, here’s how to do so with the least risk.
Now that we’re a year into the pandemic, what have we learned, and how can we plan for next year?
Why a new study is not necessarily bad news for your COVID-19 immune response. Plus the Moon’s moisture, and new successes for livestock ‘super daddies.’
STEM educators across the country share their strategies, challenges, and experiences teaching during the COVID crisis.
Dream researcher Dierdre Barrett has been collecting COVID dreams since March. Find out about the surprisingly common themes in dreams during the pandemic.
During this week’s debate, President Trump made misleading claims about a timeline for a COVID-19 vaccine. Here’s what the experts have to say.
Sophie Bushwick talks “Long COVID,” reinfection, and how to stay safe from the virus when going to the polls.
Reporter Umair Irfan discusses the experimental treatments President Trump received and who else in the White House may have been infected.
As President Trump promises a vaccine before the election, some of the largest pharmaceutical companies plan to keep politics out of science.
Headlines disagree about kids and COVID-19. Here’s what the data says.
Questions swirl around how to prioritize who gets the first COVID-19 vaccines. Plus, an update on Space X’s Starlink satellite constellation.
As recovered patients return home, medical professionals are learning about lingering health effects from serious cases of COVID-19.
Here’s what you should know about coronavirus and children, the latest in vaccine development, and new research into aerosols and spike mutations.
The National Institutes of Health completed a phase one trial on a vaccine created by the company Moderna.
States are opening up. Should you expand your social life? How to assess and manage your risk during the pandemic summer.
Uncertainty is hard for everyone. Here’s how caretakers can support kids and teens during social distancing.
How scientists are using sewage to trace the pandemic. Plus, the toll fireworks can take on the lungs, and a birdsong gone viral.
‘America’s Doctor’ provides public health lessons from the AIDS epidemic, and strategies to make it out of the COVID-19 crisis.
COVID-19 has decreased trips to the pediatrician, leaving kids vulnerable to disease.
From second waves to vaccines, “America’s doctor” gives advice on how the country should reopen after COVID-19.
A Harvard research team finds that an increase of one part per billion of air pollution is linked with an 8% increase in COVID-19 mortality.
Plus, a breakdown of this week’s COVID-19 news, including what we do and don’t know about the virus in semen and coronavirus mutations.
COVID-19 is disproportionately impacting Black, Latino, and Native American communities. Why?
A handful of COVID-19 patients under the age of fifty have experienced strokes, raising questions about the virus.
Virologist Angela Rasmussen clears up details on reactivation of the coronavirus in recovered patients and a study looking at runners and bikers droplet clouds.
The COVID-19 crisis is restricting patients’ access to regular care.
Are you following stay-at-home orders? In some countries, the government will use cell phone data to make sure.
Due to shortages of crucial supplies, healthcare workers ask volunteers to make medical masks.
What you need to know about the CDC’s new face mask guidelines and an experimental COVID-19 treatment launching in New York.
How citizen scientists can help the CDC track the spread of coronavirus in the United States.
Virologist Angela Rasmussen returns to explain the studies behind the stories on your news feed.
If COVID-19 spreads in the U.S., hospitals have ways to prepare. Public health experts explain why more testing and protecting healthcare workers will be key.
Scientists have sequenced the genome of the new coronavirus from two patients in Washington state.
Nearly 10,000 cases have been confirmed worldwide, as of January 31. Experts consider measures that could be put in place to halt the spread of the pathogen.
Changes in how countries are diagnosing infection with the coronavirus can make shifting numbers difficult to interpret.